Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Cited by (1,041)

Items 201–300 of 1,041

1. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
   Ruize Qu, Yi Zhang, Yanpeng Ma, Xin Zhou, Lulu Sun, Changtao Jiang, Zhipeng Zhang, Wei Fu · 2023 · Advanced Science
2. Microbiota transplantation: Concept, methodology and strategy for its modernization
   FMT-standardization Study Group, Zhang, Faming, Cui, Bota, He, Xingxiang, Nie, Yuqiang, Wu, Kaichun, Fan, Daiming · 2018 · Protein & Cell
3. Microbes and Cancer
   Dzutsev, Amiran, Badger, Jonathan H., Perez-Chanona, Ernesto, Roy, Soumen, Salcedo, Rosalba, Smith, Carolyne K., Trinchieri, Giorgio · 2017 · Annual Review of Immunology
4. PD-1 and PD-L1 antibodies in cancer: current status and future directions
   Arjun Vasant Balar, Jeffrey S. Weber · 2017 · Cancer Immunology Immunotherapy
5. Safety of combining radiotherapy with immune-checkpoint inhibition
   William L. Hwang, Luke Pike, Trevor Joseph Royce, Brandon Arvin Virgil Mahal, Jay S. Loeffler · 2018 · Nature Reviews Clinical Oncology
6. Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade
   Sun, Shan, Luo, Lingjie, Liang, Wenhua, Yin, Qian, Guo, Jing, Rush, Anthony M., Lv, Zhibao, Liang, Qiming, Fischbach, Michael A., Sonnenburg, Justin L. et al. · 2020 · Proceedings of the National Academy of Sciences
7. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course
   Melanie Schirmer, Lee A. Denson, Hera C. Vlamakis, Eric A. Franzosa, Sonia Thomas, Nathan Gotman, Paul A. Rufo, Susan S. Baker, Cary G. Sauer, James F. Markowitz et al. · 2018 · Cell Host & Microbe
8. Microbiome in healthy skin, update for dermatologists
   Dréno, B., Araviiskaia, E., Berardesca, E., Gontijo, G., Sanchez Viera, M., Xiang, L.F., Martin, R., Bieber, T. · 2016 · Journal of the European Academy of Dermatology and Venereology
9. Targeting the gut microbiota for cancer therapy
   Fernandes, Miriam R., Aggarwal, Poonam, Costa, Raquel G. F., Cole, Alicia M., Trinchieri, Giorgio · 2022 · Nature Reviews Cancer
10. Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
    Peters, Brandilyn A., Wilson, Melissa, Moran, Una, Pavlick, Anna, Izsak, Allison, Wechter, Todd, Weber, Jeffrey S., Osman, Iman, Ahn, Jiyoung · 2019 · Genome Medicine
11. Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer
    Chen, Yang, Yang, Sujuan, Tavormina, Jena, Tampe, Desiree, Zeisberg, Michael, Wang, Huamin, Mahadevan, Krishnan K., Wu, Chang-Jiun, Sugimoto, Hikaru, Chang, Chia-Chi et al. · 2022 · Cancer Cell
12. Immune mechanisms of toxicity from checkpoint inhibitors
    S. Jennifer Wang, Stephanie K. Dougan, Michael Lawrence Dougan · 2023 · Trends in cancer
13. Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel
    Han, Kai, Nam, Jutaek, Xu, Jin, Sun, Xiaoqi, Huang, Xuehui, Animasahun, Olamide, Achreja, Abhinav, Jeon, Jin Heon, Pursley, Benjamin, Kamada, Nobuhiko et al. · 2021 · Nature Biomedical Engineering
14. TH17 cell heterogeneity and its role in tissue inflammation
    Schnell, Alexandra, Littman, Dan R., Kuchroo, Vijay K. · 2023 · Nature Immunology
15. Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
    Despoina Chrysostomou, Lauren A. Roberts, Julian Roberto Marchesi, James K. Kinross · 2022 · Gastroenterology
16. Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer
    Xue Dong, Pei Pan, Diwei Zheng, Peng Bao, Xuan Zeng, Xian‐Zheng Zhang · 2020 · Science Advances
17. Dysbiosis of gut microbiota in promoting the development of colorectal cancer
    Shaomin Zou, Lekun Fang, Mong‐Hong Lee · 2017 · Gastroenterology report
18. Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers
    Jinzhu Mao, Dongxu Wang, Junyu Long, Yang Xu, Jianzhen Lin, Yiwei Song, Fucun Xie, Ziyu Xun, Yanyu Wang, Yunchao Wang et al. · 2021 · Journal for ImmunoTherapy of Cancer
19. Microbiome at the Frontier of Personalized Medicine
    Purna Kashyap, Nicholas Chia, Heidi Nelson, Eran Segal, Eran Elinav · 2017 · Mayo Clinic Proceedings
20. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy
    Stephen Lawrence Shiao, Kathleen M. Kershaw, Jose J. Limon, Sungyong You, Junhee Yoon, Emily Y. Ko, Jlenia Guarnerio, Alka A. Potdar, Dermot P.B. McGovern, Shikha Bose et al. · 2021 · Cancer Cell
21. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
    Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Qing Yu · 2022 · Gut
22. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance
    Anne Tuomisto, Markus J. Mäkinen, Juha P. Väyrynen · 2019 · World Journal of Gastroenterology
23. Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer
    Xuan Yi, Hailin Zhou, Yu Chao, Saisai Xiong, Jing Zhong, Zhifang Chai, Kai Yang, Zhuang Liu · 2020 · Science Advances
24. Drug-microbiota interactions: an emerging priority for precision medicine
    Qing Chun Zhao, Yao Chen, Weihua Huang, Honghao Zhou, Wei Zhang · 2023 · Signal Transduction and Targeted Therapy
25. Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
    Mei‐Yin Zhang, Chao-jun Liu, Jing Tu, Min Tang, Milad Ashrafizadeh, Noushin Nabavi, Gautam Sethi, Peiqing Zhao, Shijian Liu · 2025 · Molecular Cancer
26. Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer
    Rea Bingula, Marc Filaire, Nina Radosevic‐Robin, Mathieu Bey, Jean‐Yves Berthon, Annick Bernalier‐Donadille, Marie‐Paule Vasson, Edith Filaire · 2017 · Journal of Oncology
27. Accounting for reciprocal host–microbiome interactions in experimental science
    Thaddeus S. Stappenbeck, Herbert W. Virgin · 2016 · Nature
28. Adaptive immune education by gut microbiota antigens
    Qing Sheng Zhao, Charles O. Elson · 2018 · Immunology
29. Revisit gut microbiota and its impact on human health and disease
    Ruixue Ding, Wei-Rui Goh, Rina Wu, Xiqing Yue, Xue Gang Luo, Wei Wei Thwe Khine, Junrui Wu, Yuan Kun Lee · 2019 · Journal of Food and Drug Analysis
30. The microbiota and microbiome in pancreatic cancer: more influential than expected
    Miao-Yan Wei, Si Shi, Chen Liang, Qing-Cai Meng, Jie Hua, Yi-Yin Zhang, Jiang Liu, Bo Zhang, Jin Xu, Xianjun Yu · 2019 · Molecular Cancer
31. Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer
    Scott J. Bultman · 2016 · Molecular Nutrition & Food Research
32. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases
    Konrad Aden, Ateequr Rehman, Silvio Waschina, Wei-Hung Pan, Alesia Walker, Marianna Lucio, Alejandro Mena Nunez, Richa Bharti, Johannes Zimmerman, Johannes Bethge et al. · 2019 · Gastroenterology
33. Enterocolitis due to immune checkpoint inhibitors: a systematic review
    Émilie Soularue, Patricia Lepage, Jean Frédéric Colombel, Clélia Coutzac, David M. Faleck, Lysiane Marthey, Michael Collins, Nathalie Chaput, Caroline Robert, Franck Carbonnel · 2018 · Gut
34. Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
    Marc Oliva, Anna Spreafico, Miren Taberna, Laia Alemany, Bryan A. Coburn, Ricard Mesı́a, Lillian L. Siu · 2018 · Annals of Oncology
35. Checkpoint inhibitor immunotherapy in kidney cancer
    Wenxin Vincent Xu, Michael B. Atkins, David F. McDermott · 2020 · Nature Reviews Urology
36. Potential Role of the Gut Microbiome In Colorectal Cancer Progression
    Jae-Ho Kim, Heung Kyu Lee · 2022 · Frontiers in Immunology
37. Bacterial metabolism affects the C. elegans response to cancer chemotherapeutics
    García-González, Aurian P., Ritter, Ashlyn D., Shrestha, Shaleen, Andersen, Erik C., Yilmaz, L. Safak, Walhout, Albertha J.M. · 2017 · Cell
38. Fusobacterium nucleatum and colorectal cancer: A review
    Shang, Fu-Mei, Liu, Hong-Li · 2018 · World Journal of Gastrointestinal Oncology
39. Intratumoural microbiota: a new frontier in cancer development and therapy
    Yaqi Cao, Hui Xia, Xueyun Tan, Chunwei Shi, Yanling Ma, Daquan Meng, Mengmeng Zhou, Zhilei Lv, Sufei Wang, Yang Jin · 2024 · Signal Transduction and Targeted Therapy
40. Gut microbiome and cancer immunotherapy
    Weina Li, Yu Deng, Qian Chu, Peng Zhang · 2019 · Cancer Letters
41. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
    Ilseon Hwang, Jeong Won Kim, Kris Ylaya, Eun Joo Chung, Haruhisa Kitano, Candice D. Perry, Jun Hanaoka, Junya Fukuoka, Joon‐Yong Chung, Stephen M. Hewitt · 2020 · Journal of Translational Medicine
42. Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
    Simpson, Rebecca C., Shanahan, Erin R., Batten, Marcel, Reijers, Irene L. M., Read, Mark, Silva, Ines P., Versluis, Judith M., Ribeiro, Rosilene, Angelatos, Alexandra S., Tan, Jian et al. · 2022 · Nature Medicine
43. Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism?
    Dominik Ternes, Jessica Karta, Mina Tsenkova, Paul Wilmes, Serge Haan, Elisabeth Letellier · 2020 · Trends in Microbiology
44. Microbiota-derived metabolite promotes HDAC3 activity in the gut
    Shu-en Wu, Seika Hashimoto‐Hill, Vivienne Woo, Emily M. Eshleman, Jordan Whitt, Laura Engleman, Rebekah A. Karns, Lee A. Denson, David B Haslam, Theresa Alenghat · 2020 · Nature
45. Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease
    Niv Zmora, David Zeevi, Tal Korem, Eran Segal, Eran Elinav · 2016 · Cell Host & Microbe
46. Systems Biology of Metabolism
    Nielsen, Jens · 2017 · Annual Review of Biochemistry
47. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome
    Ziying Zhang, Haosheng Tang, Peng Chen, Hui Xie, Yongguang Tao · 2019 · Signal Transduction and Targeted Therapy
48. The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
    Elkrief, A., Derosa, L., Kroemer, G., Zitvogel, L., Routy, B. · 2019 · Annals of Oncology
49. Nanotechnology intervention of the microbiome for cancer therapy
    Wantong Song, Aaron C. Anselmo, Leaf Huang · 2019 · Nature Nanotechnology
50. Microbiome-based interventions to modulate gut ecology and the immune system
    Thomas C. A. Hitch, Lindsay J. Hall, Sarah Kate Walsh, Gabriel E. Leventhal, Emma Marie Caroline Slack, Tomás de Wouters, Jens Walter, Thomas Clavel · 2022 · Mucosal Immunology
51. A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota
    Messaoudene, Meriem, Pidgeon, Reilly, Richard, Corentin, Ponce, Mayra, Diop, Khoudia, Benlaifaoui, Myriam, Nolin-Lapalme, Alexis, Cauchois, Florent, Malo, Julie, Belkaid, Wiam et al. · 2022 · Cancer Discovery
52. Cardiotoxicity of immune checkpoint inhibitors
    Gilda Varricchi, Maria Rosaria Galdiero, Giancarlo Marone, Gjada Criscuolo, Maria Triassi, Domenico Bonaduce, Gianni Marone, Carlo Gabriele Tocchetti · 2017 · ESMO Open
53. Bacteroides and related species: The keystone taxa of the human gut microbiota
    Jae Hyun Shin, Glenn Tillotson, Tiffany N. MacKenzie, Cirle Alcantara Warren, Hannah M. Wexler, Ellie J. C. Goldstein · 2024 · Anaerobe
54. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review
    Shaheen Khan, David E. Gerber · 2019 · Seminars in Cancer Biology
55. Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer
    Ioannis Koliarakis, Ippokratis Messaritakis, Τaxiarchis Κonstantinos Νikolouzakis, George Hamilos, John Souglakos, John Tsiaoussis · 2019 · International Journal of Molecular Sciences
56. A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
    Qiqing Yang, Bin Wang, Qinghui Zheng, Heyu Li, Xuli Meng, Fangfang Zhou, Long Zhang · 2023 · Advanced Science
57. Mechanisms of immune activation and regulation: lessons from melanoma
    Shelly Kalaora, Adi Nagler, Jennifer Ann Wargo, Yardena Samuels · 2022 · Nature reviews. Cancer
58. The intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications
    Michael T. Spiotto, Yang‐Xin Fu, Ralph R. Weichselbaum · 2016 · Science Immunology
59. Immune checkpoints in the tumor microenvironment
    Salman M. Toor, Varun Sasidharan Nair, Julie V. Decock, Eyad Elkord · 2019 · Seminars in Cancer Biology
60. Hallmarks of response to immune checkpoint blockade
    Alexandria P. Cogdill, Miles Cameron Andrews, Jennifer Ann Wargo · 2017 · British Journal of Cancer
61. A low-cost paper-based synthetic biology platform for analyzing gut microbiota and host biomarkers
    Melissa K. Takahashi, Xiao Tan, Aaron J. Dy, Dana Braff, Reid Akana, Yoshikazu Furuta, Nina M. Donghia, Ashwin N. Ananthakrishnan, James J. Collins · 2018 · Nature Communications
62. Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts
    Jonathan E. Wosen, Dhriti Mukhopadhyay, Claudia Macaubas, Elizabeth Mellins · 2018 · Frontiers in Immunology
63. Current and future immunotherapeutic approaches in pancreatic cancer treatment
    Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, Ali‐Akbar Delbandi · 2024 · Journal of Hematology & Oncology
64. The neuropeptide VIP confers anticipatory mucosal immunity by regulating ILC3 activity
    Cyril Seillet, Kylie Luong, Julie Tellier, Nicolas Jacquelot, Rui Dong Shen, Peter F. Hickey, Verena C. Wimmer, Lachlan W. Whitehead, Kelly L. Rogers, Gordon K. Smyth et al. · 2019 · Nature Immunology
65. Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors
    Sophia C. Weinmann, David S. Pisetsky · 2019 · Rheumatology
66. Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade
    Wang, Feng, Yin, Qian, Chen, Liang, Davis, Mark M. · 2018 · Proceedings of the National Academy of Sciences
67. The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy
    Ariel Ramírez-Labrada, Dolores Isla, Angel Artal, Maykel A. Arias, Antonio Rezusta, Julián Pardo, Eva M. Gálvez · 2020 · Trends in cancer
68. Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology
    Mark Selby, John Engelhardt, Robert J. Johnston, Li-Sheng Lu, Minhua Han, Kent B. Thudium, Dapeng Yao, Michael M. Quigley, Jose Valle, Changyu Wang et al. · 2016 · PLoS ONE
69. The contribution of culturomics to the repertoire of isolated human bacterial and archaeal species
    Bilen, Melhem, Dufour, Jean-Charles, Lagier, Jean-Christophe, Cadoret, Fréderic, Daoud, Ziad, Dubourg, Grégory, Raoult, Didier · 2018 · Microbiome
70. Designing nanomedicine for immuno-oncology
    Wen Jiang, Christina A. Von Roemeling, Yuanxin Chen, Yaqing Qie, Xiujie Liu, Jianzhu Chen, Betty Y.S. Kim · 2017 · Nature Biomedical Engineering
71. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee
    Mari A. Mino-Kenudson, Kurt Alex Schalper, Wendy A. Cooper, Sanja Đačić, Fred R. Hirsch, Deepali Jain, Fernando López‐Ríos, Ming‐Sound Tsao, Yasushi Yatabe, Mary Beth Beasley et al. · 2022 · Journal of Thoracic Oncology
72. The role of cytokines in T‐cell memory in health and disease
    Miro E. Raeber, Yves Zurbuchen, Daniela Impellizzieri, Onur Boyman · 2018 · Immunological Reviews
73. The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
    Alexandra Schnell, Lloyd Bod, Asaf Madi, Vijay Kumar Kuchroo · 2020 · Cell Research
74. Hallmarks of cancer—the new testament
    Sasi S. Senga, Richard Philip Grose · 2021 · Open Biology
75. Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell
    Zhu, Xinhai, Li, Ke, Liu, Guichao, Wu, Ruan, Zhang, Yan, Wang, Siying, Xu, Meng, Lu, Ligong, Li, Peng · 2023 · Gut Microbes
76. A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity
    Prabhakaran Kumar, Palash Bhattacharya, Bellur S. Prabhakar · 2018 · Journal of Autoimmunity
77. Myeloid suppressor cells in cancer and autoimmunity
    Sica, Antonio, Massarotti, Marco · 2017 · Journal of Autoimmunity
78. Checkpoint inhibitors in triple‐negative breast cancer (TNBC): Where to go from here
    Maryann J. Kwa, Sylvia Adams · 2018 · Cancer
79. Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
    Kristina Buder‐Bakhaya, Jessica C. Hassel · 2018 · Frontiers in Immunology
80. Advancing to the era of cancer immunotherapy
    Yun Wang, Min Wang, Hao‐Xiang Wu, Rui‐Hua Xu · 2021 · 癌症：英文版
81. The promise of the gut microbiome as part of individualized treatment strategies
    Schupack, Daniel A., Mars, Ruben A. T., Voelker, Dayne H., Abeykoon, Jithma P., Kashyap, Purna C. · 2022 · Nature Reviews Gastroenterology & Hepatology
82. Innate Immunity and Cancer Pathophysiology
    Laura Maiorino, Juliane Daßler‐Plenker, Lijuan Sun, Mikala Egeblad · 2021 · Annual Review of Pathology Mechanisms of Disease
83. Cytokine-Induced Modulation of Colorectal Cancer
    Lukas Franz Mager, Marie-Hélène Wasmer, Tilman T. Rau, Philippe Krebs · 2016 · Frontiers in Oncology
84. Transgenic Mouse Models in Cancer Research
    Urša Lampreht Tratar, Simon Horvat, Maja Čemažar · 2018 · Frontiers in Oncology
85. Microbiota effects on cancer: From risks to therapies
    Rea, Domenica, Coppola, Giovanni, Palma, Giuseppe, Barbieri, Antonio, Luciano, Antonio, Del Prete, Paola, Rossetti, Sabrina, Berretta, Massimiliano, Facchini, Gaetano, Perdonà, Sisto et al. · 2018 · Oncotarget
86. Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment
    Botticelli, Andrea, Vernocchi, Pamela, Marini, Federico, Quagliariello, Andrea, Cerbelli, Bruna, Reddel, Sofia, Del Chierico, Federica, Di Pietro, Francesca, Giusti, Raffaele, Tomassini, Alberta et al. · 2020 · Journal of Translational Medicine
87. Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer
    Jérémy Goc, Mengze Lv, Nicholas J. Bessman, Anne-Laure Flamar, Sheena Sahota, Hiroaki Suzuki, Fei Teng, Gregory Putzel, Gérard Eberl, David R. Withers et al. · 2021 · Cell
88. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5−/− mice
    Li, Yan, Tinoco, Roberto, Elmén, Lisa, Segota, Igor, Xian, Yibo, Fujita, Yu, Sahu, Avinash, Zarecki, Raphy, Marie, Kerrie, Feng, Yongmei et al. · 2019 · Nature Communications
89. Rational Cancer Treatment Combinations: An Urgent Clinical Need
    Julia Boshuizen, Daniel S. Peeper · 2020 · Molecular Cell
90. Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade
    Tavi Nathanson, Arun Ahuja, Alex Rubinsteyn, Bülent Arman Aksoy, Matthew David Hellmann, Diana Miao, Eliezer M. Van Allen, Taha Merghoub, Jedd D. Wolchok, Alexandra Snyder et al. · 2016 · Cancer Immunology Research
91. Current Perspectives in Cancer Immunotherapy
    Theodoulakis Christofi, Stavroula Baritaki, Luca Falzone, Massimo Libra, Apostolos Zaravinos · 2019 · Cancers
92. Cancer immunotherapy: it’s time to better predict patients’ response
    Charlotte Pilard, Marie Ancion, Philippe Delvenne, Guy Jérusalem, Pascale Hubert, Michael F. Herfs · 2021 · British Journal of Cancer
93. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside
    Darleny Y. Lizardo, Chaoyuan Kuang, Suisui Hao, Jian Yu, Yi Huang, Lin Zhang · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
94. The microbiome in prostate inflammation and prostate cancer
    Corey M. Porter, Eva Shrestha, Lauren B. Peiffer, Karen Sandell Sfanos · 2018 · Prostate Cancer and Prostatic Diseases
95. The cancer microbiome
    Elinav, Eran, Garrett, Wendy S., Trinchieri, Giorgio, Wargo, Jennifer · 2019 · Nature Reviews Cancer
96. The role of the vaginal microbiome in gynaecological cancer
    Miriam Champer, AM Wong, Jackson Champer, Ilana Brito, Philipp W. Messer, JY Hou, JD Wright · 2017 · BJOG An International Journal of Obstetrics & Gynaecology
97. Melanoma models for the next generation of therapies
    E. Elizabeth Patton, Kristen L. Mueller, David J. Adams, Niroshana Anandasabapathy, Andrew E. Aplin, Corine Bertolotto, Marcus Bosenberg, Craig J. Ceol, Christin Elizabeth Burd, Ping Chi et al. · 2021 · Cancer Cell
98. Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities
    Dachao Liang, Ross Ka‐Kit Leung, Wenda Guan, William W. Au · 2018 · Gut Pathogens
99. Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging
    Arya Biragyn, Luigi Ferrucci · 2018 · The Lancet Oncology
100. Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors
     Nathan O. Siemers, James L. Holloway, Chang Han, Scott D. Chasalow, Petra Ross‐Macdonald, Charles F. Voliva, Joseph D. Szustakowski · 2017 · PLoS ONE